产品
  • 产品
  • 供应商
  • 采购
  • 资讯
  • 会展
首页 制药产品大全 药品制剂 Ginkgolide drip...

Ginkgolide dripping pill

2026-02-27
成都市

产品详情

Ginkgolide dripping pill
心脑血管及循环系统类制剂
Ginkgolide dripping pill
北美洲,中/南美洲,西欧,东欧,大洋洲,亚洲,中东,非洲

产品描述

Active ingredients: bilobalide, ginkgolide A, ginkgolide B and ginkgolide C, etc.

Description: yellowish dripping pill, bitter.

Dosage Form: oral solid preparation.
Indications: For the prevention/treatment of ischemic cerebral disease.

Strength: 10mg/pill.
Storage: Keep airtight in a dry and cool place at normal temperature.

Packaging: Pottery bottle for medical use, 150 pills/bottle. (Can be customized based on customer's order.)

Shelf Life: 18 months
Usage and Administration: Ginkgolide dripping pill is given 30~50mg as single oral dose, 3 times a day.
Contradictions:
1. Patients with a history of hypersensitivity or adverse reaction to the product or any other finished Ginkgo products.
2. Patients with a history of severe hypersensitivity.
3. Contradicted in pregnant and lactating women.

 

Baiyu provide CDMO service for:

FDFs & APIs
Primary & secondary packaging
Warehousing
Commercial scale, pilot scale, laboratory scale

You are warmly welcomed to contact us for business cooperation.

剂型
Dosage Form

生产线(条)
Poduction Lines

年产能
Annual Capacity 

注射剂
Injection

8

650,000,000

口服固体制剂
Oral Solid

3

700,000,000

原料药和中间体
API & Intermediates

3

8,000 Kg

中药前处理和提取
TCM Extraction

2

5,000,000 Kg 

sales@baiyu.cn

www.baiyujituan.com

四川宏明博思药业有限公司
访问店铺
注册资本
公司地址
联系人

公司简介

四川宏明博思药业有限公司成立于2013年,专注于原料药和制剂的生产。现有员工400余人,主要生产高端剂型如注射剂、冻干粉针剂、片剂和胶囊剂。宏明博思的冻干粉针制剂生产线已获得EU GMP,并通过巴西ANVISA现场检查。目前四川宏明博思冻干粉针制剂的多个产品在巴西、智利、秘鲁、危地马拉、泰国、菲律宾、马来西亚、南非、澳大利亚等开展注册中。Sichuan Omnis Pharmaceutical Co., Ltd. was established in 2013, focusing on the manufacture of FDFs and APIs, located in Sichuan Chengdu, China. It currently has more than 400 employees and mainly produces high-end dosage forms such as injections, lyophilized powder injections, tablets and capsules. Omnis has granted China/EU/ANVISA/PICs GMP for lyophilized powder injection line. Currently, multiple products of lyophilized powder injection are undergoing registration in Brazil, Chile, Peru, Guatemala, Thailand, the Philippines, Malaysia, South Africa, Australia, and other countries.
业务类型:
成立日期:
年营业额:
主营产品类别: